Dr. Weike Pei obtained his Ph.D. in Immunology at Heidelberg University in 2018. In graduate school, he worked with Dr. Hans-Reimer Rodewald on cell fate decision of hematopoietic stem cells. Following a one-year postdoctoral training at the German Cancer Research Center (DKFZ), he joined Dr. Vijay Kuchroo’s lab at Harvard Medical School/Brigham and Women’s Hospital as a Research Fellow, working on immune regulation and cancer immunotherapy. In 2022, Dr. Weike Pei joined Westlake University as an Assistant Professor at School of Life Sciences. His research is published in Nature, Cell Stem Cell, Nature Protocols, and other journals. Dr. Pei has received several awards including MIT Technology Review Innovators Under 35 (China), CRI Eugene V. Weissman Fellow and CRI Irvington Postdoctoral Fellowship.

Dr. Pei’s previous research was focused on the development and application of novel lineage tracing technologies for understanding cell fate decision. By integrating developmental biology, immunology, systems biology and synthetic biology, Pei lab is developing multi-dimensional single-cell lineage tracing technologies, which aims to study cell fate regulation at genetic, epigenetic, transcriptional, and spatial-temporal scales. Using novel single cell approaches, Pei lab is investigating the development and regeneration of the blood and immune system under physiological conditions and challenges such as cancer, infection and aging.